News
The Drugs Controller General of India Has Granted Approval to Sanofi & Glaxo Smith ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'The Drugs Controller General of India has granted approval to Sanofi & Glaxo Smith Kline to conduct Phase-III clinical study, to assess the safety, efficacy & immunogenicity of their adjuvanted recombinant-protein #Covid19 vaccine candidate in India, the pharma giants announced.'
The Drugs Controller General of India has granted approval to Sanofi & Glaxo Smith Kline to conduct Phase-III clinical study, to assess the safety, efficacy & immunogenicity of their adjuvanted recombinant-protein #Covid19 vaccine candidate in India, the pharma giants announced. pic.twitter.com/q1V6BzzUTX— IANS Tweets (@ians_india) July 8, 2021
(The above story first appeared on LatestLY on Jul 08, 2021 01:56 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
